UBS sets Wave Life Sciences price target at $11 per share
UBS initiated coverage of Wave Life Sciences with a Buy rating, according to the supplied report.
Site Search
Search market news
Find public news by keyword, exact ticker, category and date.
Matching instruments
Open a ticker page for its news coverage. The news search below stays a text search.
News Feed
2 results loaded, newest first. End of these results. The latest changes are still being indexed. Try again shortly for updated results.
Zscaler reports 25% ARR growth, raises AI security focus
Zscaler said fourth-quarter annual recurring revenue rose 25% and non-GAAP operating margin reached 24.3%, while Security for AI bookings increased more than 50% sequentially.